Journal Watch

karenskjeiKaren L. Skjei, M.D.
Assistant Professor,
Department of Neurology Co-Director,
Epilepsy Surgery Program Director,
Epilepsy Monitoring Unit,
Norton Children's Hospital

Dr. Karen Skjei is an assistant professor of Neurology and Pediatrics at the University of Louisville. She completed her undergraduate studies at Duke University, and her medical education at the University of California at San Francisco School of Medicine. She completed a residency in Pediatrics and a fellowship in Child and Adolescent Neurology at the Mayo Clinic in Rochester, New York. She completed a fellowship in Neurophysiology and Epilepsy at the Children’s Hospital of Philadelphia. Dr Skjei is currently Editor of the ICNApedia Journal Watch

87 results - showing 11 - 20
1 2 3 4 5 6 7 8 9
Ordering
 
0.0
 
0.0 (0)
AS An-Sofie Schoonjans and Karen Skjei Updated March 04, 2020 532 0
Eur J Paediatr Neurol. 2019 Nov;23(6):827-831.
 
0.0
 
0.0 (0)
CN Christelle Nel Updated February 16, 2020 13902 0
J Am Acad Child Adolesc Psychiatry 2019; 58(9): 853-865
 
0.0
 
0.0 (0)
CN Christelle Nel Updated February 16, 2020 8574 0
European Journal of Paediatric Neurology 23 (2019) 546 -559
 
0.0
 
0.0 (0)
SC Sireesha Chinthaparthy, MD Updated January 06, 2020 14806 1
Pediatric Neurology 93 (2019) 21-26 / https://doi.org/10.1016/j.pediatrneurol.2018.10.018
 
0.0
 
0.0 (0)
Karen L Skjei
Karen L Skjei
Updated January 06, 2020 11799 0
Pediatric neurology 101 (2019): 18-25.
 
0.0
 
5.0 (1)
William Qubty
William Qubty
Updated December 02, 2019 2467 0
Objective To provide updated evidence-based recommendations for migraine prevention using pharmacologic treatment with or without cognitive behavioral therapy in the pediatric population. Methods The authors systematically reviewed literature from January 2003 to August 2017 and developed practice recommendations using the American Academy of Neurology 2011 process, as amended. Results Fifteen Class I–III studies on migraine prevention in children and adolescents met inclusion criteria. There is insufficient evidence to determine if children and adolescents receiving divalproex, onabotulinumtoxinA, amitriptyline, nimodipine, or flunarizine are more or less likely than those receiving placebo to have a reduction in headache frequency. Children with migraine...
 
0.0
 
0.0 (0)
SC Sireesha Chinthaparthi Updated February 22, 2020 30091 0
Pediatric Neurology 2018: 78, 55-60
 
0.0
 
0.0 (0)
DF Daniel Freedman Updated February 22, 2020 20162 0
Pediatric Neurology 2019: 97, 56-63
 
0.0
 
0.0 (0)
Karen L Skjei
Karen L Skjei
Updated December 01, 2019 30244 0
Indian Pediatrics 2019: 56, 643-646
Abstract Objective: To compare the efficacy and safety of intravenous Levetiracetam and Phenobarbitone in the treatment of neonatal seizures. Design: Open labelled, Randomized controlled trial. Setting: Level III Neonatal Intensive Care Unit (NICU). Participants: 100 neonates (0-28 days) with clinical seizures. Intervention: If seizures persisted even after correction of hypoglycemia and hypocalcemia, participants were randomized to receive either Levetiracetam (20 mg/kg) or Phenobarbitone (20 mg/kg) intravenously. The dose of same drug was repeated if seizures persisted (20 mg/kg of Levetiracetam or 10 mg/kg of Phenobarbitone) and changeover to other drug occurred if the seizures persisted even...
87 results - showing 11 - 20
1 2 3 4 5 6 7 8 9

pleasedonate